HEADER SIGNALING PROTEIN 12-MAY-99 1CM0 TITLE CRYSTAL STRUCTURE OF THE PCAF/COENZYME-A COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: P300/CBP ASSOCIATING FACTOR; COMPND 3 CHAIN: B, A; COMPND 4 FRAGMENT: HISTONE ACETYLTRANSFERASE DOMAIN; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: COCRYSTALLIZED WITH COENZYME A SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELLULAR_LOCATION: NUCLEUS; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_CELLULAR_LOCATION: CYTOPLASM; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PRSET A KEYWDS P300/CBP ASSOCIATED FACTOR, COENZYME A, ACETYLTRANSFERASE, KEYWDS 2 COACTIVATOR, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.CLEMENTS,J.R.ROJAS,R.C.TRIEVEL,L.WANG,S.L.BERGER,R.MARMORSTEIN REVDAT 5 03-APR-24 1CM0 1 REMARK REVDAT 4 27-DEC-23 1CM0 1 REMARK SEQADV REVDAT 3 24-FEB-09 1CM0 1 VERSN REVDAT 2 25-APR-01 1CM0 1 JRNL REMARK DBREF REVDAT 1 06-JUL-99 1CM0 0 JRNL AUTH A.CLEMENTS,J.R.ROJAS,R.C.TRIEVEL,L.WANG,S.L.BERGER, JRNL AUTH 2 R.MARMORSTEIN JRNL TITL CRYSTAL STRUCTURE OF THE HISTONE ACETYLTRANSFERASE DOMAIN OF JRNL TITL 2 THE HUMAN PCAF TRANSCRIPTIONAL REGULATOR BOUND TO COENZYME JRNL TITL 3 A. JRNL REF EMBO J. V. 18 3521 1999 JRNL REFN ISSN 0261-4189 JRNL PMID 10393169 JRNL DOI 10.1093/EMBOJ/18.13.3521 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.5 REMARK 3 NUMBER OF REFLECTIONS : 17925 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1761 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 35 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.32 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 463 REMARK 3 BIN R VALUE (WORKING SET) : 0.2760 REMARK 3 BIN FREE R VALUE : 0.3460 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 50 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2606 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 96 REMARK 3 SOLVENT ATOMS : 109 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 41.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.00000 REMARK 3 B22 (A**2) : -1.00000 REMARK 3 B33 (A**2) : 2.01400 REMARK 3 B12 (A**2) : -7.63000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.890 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 3.340 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.310 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.220 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.900 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.860 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 39.00 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ACO_XPLOR_PAR.TXT REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ACO_XPLOR_TOP.TXT REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1CM0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-MAY-99. REMARK 100 THE DEPOSITION ID IS D_1000001054. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X4A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.009 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17943 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 4.00000 REMARK 200 FOR THE DATA SET : 18.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.70 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 15.5000 REMARK 200 FOR SHELL : 4.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: APOTGCN5 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 5MG/ML OF P/CAF WITH 2 M EXCESS REMARK 280 COFACTOR, 100MM TRIS, 1.5 M LITHIUM SULFATE, PH 8.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 64 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z REMARK 290 5555 Y,-X+Y,Z+1/3 REMARK 290 6555 X-Y,X,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 25.95000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 51.90000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 25.95000 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 51.90000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET B 491 REMARK 465 ILE B 654 REMARK 465 PRO B 655 REMARK 465 TYR B 656 REMARK 465 THR B 657 REMARK 465 GLU B 658 REMARK 465 MET A 491 REMARK 465 PRO A 655 REMARK 465 TYR A 656 REMARK 465 THR A 657 REMARK 465 GLU A 658 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU B 503 CG CD1 CD2 REMARK 470 GLN B 505 CG CD OE1 NE2 REMARK 470 GLU B 625 CG CD OE1 OE2 REMARK 470 ILE B 626 CG1 CG2 CD1 REMARK 470 LYS B 627 CG CD CE NZ REMARK 470 THR B 631 OG1 CG2 REMARK 470 TYR B 636 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG B 653 CA C O CB CG CD NE REMARK 470 ARG B 653 CZ NH1 NH2 REMARK 470 ILE A 654 CA C O CB CG1 CG2 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ARG A 653 N ILE A 654 1.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 CE2 PHE A 496 CE1 TYR A 612 3664 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 653 CA - C - N ANGL. DEV. = 42.9 DEGREES REMARK 500 ARG A 653 O - C - N ANGL. DEV. = -74.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER B 502 126.17 -22.22 REMARK 500 LEU B 503 1.21 -62.58 REMARK 500 ASN B 504 -79.42 -77.18 REMARK 500 GLN B 505 83.51 -154.13 REMARK 500 LYS B 506 21.12 -143.24 REMARK 500 PRO B 507 21.80 -73.86 REMARK 500 VAL B 634 100.17 -53.84 REMARK 500 ASN B 651 -161.64 -79.60 REMARK 500 VAL A 493 65.38 -115.03 REMARK 500 ASN A 501 68.33 -103.30 REMARK 500 ASN A 504 -118.06 -59.44 REMARK 500 ALA A 575 155.93 179.93 REMARK 500 THR A 631 -9.03 -58.63 REMARK 500 PRO A 652 143.81 -39.99 REMARK 500 ARG A 653 -33.47 -150.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 ARG A 653 -111.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE COA B 700 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE COA A 701 DBREF 1CM0 B 491 658 UNP Q92831 PCAF_HUMAN 491 658 DBREF 1CM0 A 491 658 UNP Q92831 PCAF_HUMAN 491 658 SEQADV 1CM0 MET B 491 UNP Q92831 ARG 491 CONFLICT SEQADV 1CM0 LYS B 492 UNP Q92831 GLY 492 CONFLICT SEQADV 1CM0 MET A 491 UNP Q92831 ARG 491 CONFLICT SEQADV 1CM0 LYS A 492 UNP Q92831 GLY 492 CONFLICT SEQRES 1 B 168 MET LYS VAL ILE GLU PHE HIS VAL VAL GLY ASN SER LEU SEQRES 2 B 168 ASN GLN LYS PRO ASN LYS LYS ILE LEU MET TRP LEU VAL SEQRES 3 B 168 GLY LEU GLN ASN VAL PHE SER HIS GLN LEU PRO ARG MET SEQRES 4 B 168 PRO LYS GLU TYR ILE THR ARG LEU VAL PHE ASP PRO LYS SEQRES 5 B 168 HIS LYS THR LEU ALA LEU ILE LYS ASP GLY ARG VAL ILE SEQRES 6 B 168 GLY GLY ILE CYS PHE ARG MET PHE PRO SER GLN GLY PHE SEQRES 7 B 168 THR GLU ILE VAL PHE CYS ALA VAL THR SER ASN GLU GLN SEQRES 8 B 168 VAL LYS GLY TYR GLY THR HIS LEU MET ASN HIS LEU LYS SEQRES 9 B 168 GLU TYR HIS ILE LYS HIS ASP ILE LEU ASN PHE LEU THR SEQRES 10 B 168 TYR ALA ASP GLU TYR ALA ILE GLY TYR PHE LYS LYS GLN SEQRES 11 B 168 GLY PHE SER LYS GLU ILE LYS ILE PRO LYS THR LYS TYR SEQRES 12 B 168 VAL GLY TYR ILE LYS ASP TYR GLU GLY ALA THR LEU MET SEQRES 13 B 168 GLY CYS GLU LEU ASN PRO ARG ILE PRO TYR THR GLU SEQRES 1 A 168 MET LYS VAL ILE GLU PHE HIS VAL VAL GLY ASN SER LEU SEQRES 2 A 168 ASN GLN LYS PRO ASN LYS LYS ILE LEU MET TRP LEU VAL SEQRES 3 A 168 GLY LEU GLN ASN VAL PHE SER HIS GLN LEU PRO ARG MET SEQRES 4 A 168 PRO LYS GLU TYR ILE THR ARG LEU VAL PHE ASP PRO LYS SEQRES 5 A 168 HIS LYS THR LEU ALA LEU ILE LYS ASP GLY ARG VAL ILE SEQRES 6 A 168 GLY GLY ILE CYS PHE ARG MET PHE PRO SER GLN GLY PHE SEQRES 7 A 168 THR GLU ILE VAL PHE CYS ALA VAL THR SER ASN GLU GLN SEQRES 8 A 168 VAL LYS GLY TYR GLY THR HIS LEU MET ASN HIS LEU LYS SEQRES 9 A 168 GLU TYR HIS ILE LYS HIS ASP ILE LEU ASN PHE LEU THR SEQRES 10 A 168 TYR ALA ASP GLU TYR ALA ILE GLY TYR PHE LYS LYS GLN SEQRES 11 A 168 GLY PHE SER LYS GLU ILE LYS ILE PRO LYS THR LYS TYR SEQRES 12 A 168 VAL GLY TYR ILE LYS ASP TYR GLU GLY ALA THR LEU MET SEQRES 13 A 168 GLY CYS GLU LEU ASN PRO ARG ILE PRO TYR THR GLU HET COA B 700 48 HET COA A 701 48 HETNAM COA COENZYME A FORMUL 3 COA 2(C21 H36 N7 O16 P3 S) FORMUL 5 HOH *109(H2 O) HELIX 1 1 LYS B 509 GLN B 525 1 17 HELIX 2 2 LYS B 531 VAL B 538 1 8 HELIX 3 3 SER B 578 GLU B 580 5 3 HELIX 4 4 TYR B 585 LYS B 599 1 15 HELIX 5 5 ILE B 614 GLN B 620 1 7 HELIX 6 6 LYS B 630 TYR B 633 1 4 HELIX 7 7 LYS A 509 GLN A 525 1 17 HELIX 8 8 LYS A 531 VAL A 538 1 8 HELIX 9 9 SER A 578 GLU A 580 5 3 HELIX 10 10 TYR A 585 HIS A 600 1 16 HELIX 11 11 ILE A 614 GLN A 620 1 7 HELIX 12 12 LYS A 630 TYR A 633 1 4 SHEET 1 A 4 ILE B 494 GLY B 500 0 SHEET 2 A 4 HIS B 543 LYS B 550 -1 N ILE B 549 O GLU B 495 SHEET 3 A 4 ARG B 553 PHE B 563 -1 N PHE B 560 O LYS B 544 SHEET 4 A 4 PHE B 568 VAL B 576 -1 N ALA B 575 O GLY B 557 SHEET 1 B 2 ASN B 604 ALA B 609 0 SHEET 2 B 2 THR B 644 GLU B 649 -1 N CYS B 648 O PHE B 605 SHEET 1 C 4 ILE A 494 VAL A 499 0 SHEET 2 C 4 LYS A 544 LYS A 550 -1 N ILE A 549 O GLU A 495 SHEET 3 C 4 ARG A 553 PHE A 563 -1 N PHE A 560 O LYS A 544 SHEET 4 C 4 PHE A 568 VAL A 576 -1 N ALA A 575 O GLY A 557 SHEET 1 D 2 ASN A 604 ALA A 609 0 SHEET 2 D 2 THR A 644 GLU A 649 -1 N CYS A 648 O PHE A 605 SITE 1 AC1 17 HOH B 6 HOH B 103 GLN B 525 CYS B 574 SITE 2 AC1 17 ALA B 575 VAL B 576 GLN B 581 VAL B 582 SITE 3 AC1 17 LYS B 583 GLY B 584 GLY B 586 THR B 587 SITE 4 AC1 17 TYR B 612 ALA B 613 GLY B 615 TYR B 616 SITE 5 AC1 17 PHE B 617 SITE 1 AC2 21 HOH A 1 HOH A 59 HOH A 101 GLU A 495 SITE 2 AC2 21 HIS A 497 LYS A 510 GLN A 525 CYS A 574 SITE 3 AC2 21 ALA A 575 VAL A 576 GLN A 581 VAL A 582 SITE 4 AC2 21 LYS A 583 GLY A 584 GLY A 586 THR A 587 SITE 5 AC2 21 TYR A 612 ALA A 613 GLY A 615 TYR A 616 SITE 6 AC2 21 PHE A 617 CRYST1 97.000 97.000 77.850 90.00 90.00 120.00 P 64 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010309 0.005952 0.000000 0.00000 SCALE2 0.000000 0.011904 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012845 0.00000